Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Rucaparib

EU orphan designation number: EU/3/12/1049   
Active ingredient: Rucaparib
Indication: Treatment of ovarian cancer
Sponsor: Clovis Oncology UK Limited
Sheraton House, Castle Park, Castle Hill, Cambridge CB3 0AX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Centralised Orphan - Designation EMA/OD/085/12 (2012)7226 of 10/10/2012